首頁 > 市場調查報告書 > 醫療設備

體外診斷

到 2030 年北美凝血市場預測 - 區域分析 - 按疾病適應症、類型、產品、技術和最終用戶

市場調查報告書

商品編碼

1494293

到 2030 年北美凝血市場預測 - 區域分析 - 按疾病適應症、類型、產品、技術和最終用戶

North America Coagulation Market Forecast to 2030 - Regional Analysis - by Disease Indications, Type, Offering, Technology, and End User

出版日期: 2024年03月14日 | 出版商:

The Insight Partners | 英文 102 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年北美凝血市場價值為27.1264億美元，預計2030年將達46.3326億美元；預計2022年至2030年複合年成長率為6.9%。

血液疾病盛行率的增加推動了北美凝血市場

根據國家罕見疾病組織的數據，A 型血友病是一種常見的 X 連鎖隱性遺傳疾病，也是繼馮維樂布蘭氏症之後第二常見的遺傳性凝血因子缺乏症。此外，在美國，每 5,000 名男嬰兒中就有 1 名患有 A 型血友病。根據2020 年全球血友病護理研究，隨著時間的推移，全球已識別並記錄了393,658 例出血性疾病病例，其中包括241,535 例血友病病例、87,729 例血管性血友病病例和64,394 例其他出血性疾病病例。根據國家醫學圖書館 (NLM) 的數據，2020 年美國約有 30,000-33,000 名男性受到血友病的影響。

根據美國癌症協會(CLL) 的報告，2021 年美國記錄了約21,250 例新的慢性淋巴細胞白血病病例。病人數美國受深部靜脈栓塞影響的人數可能達到 90 萬人（每 1,000 人中有 1 至 2 人）。同一消息來源估計，在美國，每年有 60,000-100,000 名美國人死於靜脈血栓栓塞。

據美國衛生與公眾服務部稱，2020 年約有 10 萬美國人被診斷患有鐮狀細胞疾病 (SCD)，這是最常見的遺傳性血液疾病之一。此外，預計到2050 年，患有SCD 的人數將增加約30%。約有66 名成年人患有免疫性血小板減少症(ITP)每年到 2022 年。

北美凝固市場概況

北美凝血市場分為美國、加拿大和墨西哥。由於血液疾病發病率不斷上升、心房顫動 (AFib) 等心血管疾病的發生率不斷增加，以及主要市場參與者從事新產品和現有產品開發，北美佔據了重要的市場佔有率。美國在北美凝血市場佔有最大佔有率。血液疾病病例的不斷增加、心血管疾病的盛行率不斷上升以及政府對預防血液疾病的支持預計將推動 2022-2030 年北美凝血市場的成長。

北美凝固市場收入及 2030 年預測（百萬美元）

北美混凝市場細分

北美凝血市場根據疾病適應症、類型、產品、技術、最終用戶和國家進行細分。

根據疾病適應症，北美凝血市場分為維生素 K 缺乏症、肝病、瀰漫性血管內凝血及肺栓塞、循環抗凝血劑的發展、血友病、馮維勒布蘭氏症等。 2022 年，肝病領域佔據北美凝血市場最大佔有率。

根據類型，北美凝血市場分為臨床實驗室分析儀和即時檢測分析儀。 2022 年，臨床實驗室分析儀細分市場將佔據更大的北美凝血市場佔有率。等。

在產品方面，北美凝血市場分為診斷與治療。至2022年，診斷細分市場將佔據更大的北美凝血市場佔有率。 D-二聚體測試、血小板功能測試等。治療部分進一步細分為抗纖溶藥物、避孕藥、去氨加壓素和免疫抑制藥物、維生素K 補充劑、血液稀釋劑、凝血酶抑制劑或血栓溶解劑、替代療法、導管輔助血栓清除等。

依技術分類，北美凝血市場分為光學技術、機械技術、電化學技術等。 2022 年，光學技術領域佔據北美凝血市場最大佔有率。

依最終用戶分類，北美凝血市場分為臨床實驗室、醫院等。 2022 年，臨床實驗室領域佔據北美凝血市場最大佔有率。

根據國家/地區，北美凝固市場分為美國、加拿大和墨西哥。 2022年，美國主導北美凝血市場。

Diagnostica Stago Inc、F Hoffmann-La Roche Ltd、Genrui Biotech Co., Ltd、Helena Laboratories Corporation、Horiba Ltd、ImproGen Diagnostik Kimya San。＆抽動。 Ltd.Sti.、Siemens Healthineers AG、Sysmex Corp 和 Transasia Bio-Medicals Ltd 是北美凝血市場的一些領先公司。

Hemophilia A is one of the common X-linked recessive disorders and the second most common inherited clotting factor deficiency after von Willebrand disease, according to the National Organization of Rare Disorders. Also, ~1 in 5,000 male infants suffers from hemophilia A in the US. According to the Global Hemophilia Care 2020 study, 393,658 bleeding disorders cases have been recognized and documented worldwide over time, including 241,535 hemophilia cases, 87,729 von Willebrand disease cases, and 64,394 other bleeding disorder cases. According to the National Library of Medicine (NLM), ~30,000-33,000 men were affected by hemophilia in the US in 2020.

As per the reports from the American Cancer Society (CLL), the US recorded ~21,250 new cases of chronic lymphocytic leukemia in 2021. A February 2020 update from the Centers for Disease Control and Prevention (CDC) states that the number of people in the US affected by deep vein thrombosis could reach 900,000 (1 to 2 per 1,000). The same source estimates that in the US 60,000-100,000 Americans die yearly from venous thromboembolism.

According to the US Department of Health & Human Services, ~100,000 Americans were diagnosed with sickle cell disease (SCD) in 2020, which is one of the most commonly inherited blood disorders. In addition, the number of people suffering from SCD is expected to grow by ~30% by 2050. The National Organization for Rare Disorders stated that immune thrombocytopenia (ITP), an autoimmune bleeding disorder, affected ~66 adults per 1 million in the US each year in 2022. Therefore, the rising prevalence of blood disorders drives the coagulation market growth.

North America Coagulation Market Overview

The North America coagulation market is segmented into the US, Canada, and Mexico. North America accounts for a significant market share owing to the growing incidences of blood disorders, increasing occurrence of cardiovascular diseases such as atrial fibrillation (AFib), and the presence of major market players engaged in new and existing product developments. The US holds the largest share of the coagulation market in North America. The burgeoning cases of blood disorders, growing prevalence of cardiovascular diseases, and government support for preventing blood disorders are anticipated to boost the North America coagulation market growth during 2022-2030.

North America Coagulation Market Revenue and Forecast to 2030 (US$ Million)

North America Coagulation Market Segmentation

The North America coagulation market is segmented based on disease indication, type, offering, technology, end user, and country.

Based on disease indication, the North America coagulation market is segmented into vitamin k deficiency, liver disease, disseminated intravascular coagulation and pulmonary embolism, development of circulating anticoagulants, hemophilia, von willebrand's disease, and others. The liver disease segment held the largest North America coagulation market share in 2022.

Based on type, the North America coagulation market is bifurcated into clinical laboratory analysers and point-of-care testing analyzers. The clinical laboratory analysers segment held a larger North America coagulation market share in 2022. Clinical laboratory analysers segment is further subsegmented into controls & calibrators, assays & reagents, instruments/systems, coagulation factors, and others.

In terms of offering, the North America coagulation market is bifurcated into diagnosis and treatment. The diagnosis segment held a larger North America coagulation market share in 2022. Diagnosis segment is further subsegmented into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, d-dimmer testing, platelets function testing, and others. Treatment segment is further subsegmented into anti-fibrinolytic drugs, birth control pills, desmopressin & immunosuppressive medicines, vitamin k supplements, blood thinners, thrombin inhibitors or thrombolytics, replacement therapy, catheter-assisted thrombus removal, and others.

By technology, the North America coagulation market is segmented into optical technology, mechanical technology, electrochemical technology, and others. The optical technology segment held the largest North America coagulation market share in 2022.

By end user, the North America coagulation market is segmented into clinical laboratories, hospitals, and others. The clinical laboratories segment held the largest North America coagulation market share in 2022.

Based on country, the North America coagulation market is categorized into the US, Canada, and Mexico. The US dominated the North America coagulation market in 2022.

Diagnostica Stago Inc, F Hoffmann-La Roche Ltd, Genrui Biotech Co, Ltd, Helena Laboratories Corporation, Horiba Ltd, ImproGen Diagnostik Kimya San. & Tic. Ltd.Sti., Siemens Healthineers AG, Sysmex Corp, and Transasia Bio-Medicals Ltd are some of the leading companies operating in the North America coagulation market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Coagulation Market - Key Industry Dynamics

4.1 Key Market Drivers:
- 4.1.1 Increasing Prevalence of Blood Disorders
- 4.1.2 Rising Prevalence of Cardiovascular Diseases
4.2 Market Restraints
- 4.2.1 High Costs Associated with Coagulation Analyzers
4.3 Market Opportunities
- 4.3.1 Growing Organic and Inorganic Strategies by Key Market Players
4.4 Future Trends
- 4.4.1 Development of Point-of-Care (POC) Coagulation Analyzers
4.5 Impact Analysis

5. Coagulation Market - North America Market Analysis

5.1 North America Coagulation Market Revenue (US$ million), 2022 - 2030

6. North America Coagulation Market - Revenue and Forecast to 2030 - by Disease Indication

6.1 Overview
6.2 North America Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
6.3 Vitamin K Deficiency
- 6.3.1 Overview
- 6.3.2 Vitamin K Deficiency: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Liver Disease
- 6.4.1 Overview
- 6.4.2 Liver Disease: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Disseminated Intravascular Coagulation and Pulmonary Embolism
- 6.5.1 Overview
- 6.5.2 Disseminated Intravascular Coagulation and Pulmonary Embolism: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Development of Circulating Anticoagulant
- 6.6.1 Overview
- 6.6.2 Development of Circulating Anticoagulant: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Hemophilia
- 6.7.1 Overview
- 6.7.2 Hemophilia: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.8 Von Willebrand's Disease
- 6.8.1 Overview
- 6.8.2 Von Willebrand's Disease: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.9 Others
- 6.9.1 Overview
- 6.9.2 Others: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Coagulation Market - Revenue and Forecast to 2030 - by Type

7.1 Overview
7.2 North America Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
7.3 Clinical Laboratory Analyzers
- 7.3.1 Overview
- 7.3.2 Clinical Laboratory Analyzers: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.3.2.1 North America Coagulation Market, by Clinical Laboratory Analyzers
7.4 Point-of-Care Testing Analyzers
- 7.4.1 Overview
- 7.4.2 Point-of-Care Testing Analyzers: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Coagulation Market - Revenue and Forecast to 2030 - by Offering

8.1 Overview
8.2 North America Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
8.3 Diagnosis
- 8.3.1 Overview
- 8.3.2 Diagnosis: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 North America Coagulation Market, by Diagnosis
8.4 Treatment
- 8.4.1 Overview
- 8.4.2 Treatment: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.4.2.1 North America Coagulation Market, by Treatment

9. North America Coagulation Market - Revenue and Forecast to 2030 - by Technology

9.1 Overview
9.2 North America Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
9.3 Optical Technology
- 9.3.1 Overview
- 9.3.2 Optical Technology: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Mechanical Technology
- 9.4.1 Overview
- 9.4.2 Mechanical Technology: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Electrochemical Technology
- 9.5.1 Overview
- 9.5.2 Electrochemical Technology: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Coagulation Market - Revenue and Forecast to 2030 - by End User

10.1 Overview
10.2 North America Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Clinical Laboratories
- 10.3.1 Overview
- 10.3.2 Clinical Laboratories: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Hospitals
- 10.4.1 Overview
- 10.4.2 Hospitals: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Others
- 10.5.1 Overview
- 10.5.2 Others: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Coagulation Market - Country Analysis

11.1 North America Coagulation Market, Revenue and Forecast to 2030

12. Coagulation Market-Industry Landscape

12.1 Overview
12.2 Growth Strategies in the Coagulation Market
12.3 Inorganic Growth Strategies
- 12.3.1 Overview
12.4 Organic Growth Strategies
- 12.4.1 Overview

13. Company Profiles

13.1 Siemens Healthineers AG
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Diagnostica Stago, Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 ImproGen Diagnostik Kimya San. & Tic. Ltd.Sti.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Sysmex Corp
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Helena Laboratories Corporation
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 F. Hoffmann-La Roche Ltd
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Genrui Biotech Co., Ltd.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Transasia Bio-Medicals Ltd
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Horiba Ltd.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. North America Coagulation Market Segmentation
Table 2. North America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 3. North America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 4. North America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 5. Optical Technologies and Their Applications
Table 6. Mechanical Technologies and Their Applications
Table 7. US Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 8. US Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 9. US Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 10. US Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 11. US Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 12. US Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 13. US Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 14. US Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 15. Canada Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 16. Canada Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 17. Canada Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 18. Canada Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 19. Canada Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 20. Canada Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 21. Canada Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 22. Canada Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 23. Mexico Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 24. Mexico Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 25. Mexico Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 26. Mexico Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 27. Mexico Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 28. US Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 29. Mexico Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 30. Mexico Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 31. Recent Inorganic Growth Strategies in the Coagulation Market
Table 32. Recent Organic Growth Strategies in the Coagulation Market
Table 33. Glossary of Terms, Coagulation Market

List Of Figures

Figure 1. North America Coagulation Market Segmentation, By Country
Figure 2. North America Coagulation Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Coagulation Market Revenue (US$ million), 2020 - 2030
Figure 5. North America Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
Figure 6. Vitamin K Deficiency: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Liver Disease: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Disseminated Intravascular Coagulation and Pulmonary Embolism: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Development of Circulating Anticoagulant: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Hemophilia: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Von Willebrand's Disease: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Others: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. North America Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
Figure 14. Clinical Laboratory Analyzers: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Point-of-Care Testing Analyzers: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. North America Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
Figure 17. Diagnosis: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Treatment: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. North America Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 20. Optical Technology: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Mechanical Technology: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Electrochemical Technology: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. North America Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
Figure 25. Clinical Laboratories: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Hospitals: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Others: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. North America Coagulation Market, 2022 (US$)(million)
Figure 29. North America Coagulation Market, By Key Countries, 2022 and 2030 (%)
Figure 30. US Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 31. Canada Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 32. Mexico Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 33. Growth Strategies in the Coagulation Market